Supplemental Table S3: Significant results of the a priori sensitivity analysis by the systematic removal of each one by onea Removal of MD 95% CI I² Comment Triglycerides (mmol/L) [-0.46, Jenkins et al 2011 - routine -0.36 <0.0001 0% 0.71 Heterogeneity was explained after removal Systolic blood pressure (mmHg) [-3.02, Jenkins et al. 2011 - intensive -1.17 0.22 0% 0.84 MD no longer significant removal 0.68] Diastolic blood pressure (mmHg) [-2.57, Jenkins et al 2011 - routine -1.17 0.10 12% 0.34 0.22] MD no longer significant after trial removal [-2.16, Jenkins et al. 2011 - intensive -0.96 0.12 0% 0.48 0.25] CRP (mg/L) [-1.07, Jenkins et al. 2003b -0.53 0.06 44% 0.12 0.02] [-1.00, Jenkins et al. 2003a -0.50 0.05 40% 0.14 MD no longer significant after removal 0.00] Jenkins et. al. 2010 - High [-0.91, -0.44 0.06 23% 0.26 MUFA 0.02] 10-year CHD Risk, % [-1.36, Jenkins et al. 2003a -0.81 0.004 0% 0.67 Heterogeneity was explained trial removal a Sensitivity analysis included the removal of a single from the meta-analyses one at a time and the summary effect was recalculated. An influential comparison was considered a comparison whose removal changed the significance, direction or magnitude (by >10%) of the pooled estimate or changed the significance of the heterogeneity estimate. Only influential comparisons are presented in this table.
Supplemental Table S3: Significant results of the a priori sensitivity analysis by the systematic removal of each one by onea Removal of MD 95% CI I² Comment Triglycerides (mmol/L) Jenkins et al 2011 - routine -0.36 [-0.46, <0.0001 0% 0.71 Heterogeneity was explained after removal Systolic blood pressure (mmHg) Jenkins et al. 2011 - intensive -1.17 [-3.02, 0.68] 0.22 0% 0.84 MD no longer significant removal Diastolic blood pressure (mmHg) Jenkins et al 2011 - routine -1.17 [-2.57, 0.22] 0.10 12% 0.34 MD no longer significant after trial removal Jenkins et al. 2011 - intensive -0.96 [-2.16, 0.25] 0.12 0% 0.48 CRP (mg/L) Jenkins et al. 2003b -0.53 [-1.07, 0.02] 0.06 44% 0.12 MD no longer significant after removal Jenkins et al. 2003a -0.50 [-1.00, 0.00] 0.05 40% 0.14 Jenkins et. al. 2010 - High MUFA -0.44 [-0.91, 0.02] 0.06 23% 0.26 10-year CHD Risk, % Jenkins et al. 2003a -0.81 [-1.36, 0.004 0% 0.67 Heterogeneity was explained trial removal a Sensitivity analysis included the removal of a single from the meta-analyses one at a time and the summary effect was recalculated. An influential comparison was considered a comparison whose removal changed the significance, direction or magnitude (by >10%) of the pooled estimate or changed the significance of the heterogeneity estimate. Only influential comparisons are presented in this table.
1-s2.0-S003306201830094X-mmc1.docx